Jawad Hassan Ahmed

Jawad Hassan Ahmed

Auto-generated profile, based on publicly available information

Jawad Hassan Ahmed

Department of Pharmacology, College of Medicine, University of Basrah, Iraq

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in Indian Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
AHAnwar S. Hassan
Anwar S. Hassan
JAJawad H. Ahmed
Jawad H. Ahmed
SASawsan S. Al-Haroon
Sawsan S. Al-Haroon
Objective: To investigate the possibility of hepatoprotective effect of Nigella sativa (NS) in INH-induced hepatotoxicity. Materials and Methods: The experiments were carried out on 24 male rabbits. They were divided into 4 groups (6 each); rabbits in group 1 were treated with INH following a standard protocol to induce hepatotoxicity. Rabbits in group 2 received starch. Group 3 received NS 1 g/kg/day before INH treatment. Group 4 rabbits were treated with NS only. Phenobarbital sodium (IP) was given to induce metabolism of INH. INH and NS were given orally. The experiment continued for 12 days; at day 13, animals were sacrificed. Liver function tests, malondialdehyde (MDA) were estimated in serum and in liver homogenates. Liver histopathological examinations were performed. Results: Histopathological changes of hepatotoxicity were found in all INH-treated rabbits. The histopathological findings were normal in three rabbits treated with NS before INH, very mild in two, and with moderate changes in one rabbit. Serum alanine aminotransferase (S.ALT) was elevated after INH treatment and returned back to the control value when NS was given before INH. Similar pattern of effect was noticed with serum aspartate aminotransferase (S.AST), S. total bilirubin, S. MDA, and Serum alkaline phosphatase. In liver homogenate, AST, ALT, and MDA were increased with INH treatment compared to the control, then decreased with NS treatment given before INH Conclusions: NS has hepatoprotective effects against INH-induced hepatotoxicity in rabbits. NS 1 g/kg proved safe, no adverse effects; no histopathological or biological abnormalities were seen.

28 June 2009 in The Medical Journal of Basrah University
Verified
Journal Article
Closed access
KMKaram-Allah S. Mahmood
Karam-Allah S. Mahmood
JAJawad H. Ahmed
Jawad H. Ahmed
AJAbdullah M. Jawad
Abdullah M. Jawad

26 June 2020 in Biomedical Reports
Verified
Journal Article
Open access
PDF file
DMDR Adel Gassab Mohammed
DR Adel Gassab Mohammed
AMAbbas Ali Mansour
Abbas Ali Mansour
JAJawad Hassan Ahmed
Jawad Hassan Ahmed
The aim of the present study was to investigate the effects of exogenous glucocorticoids (GCs), a potent cause of male hypogonadism, on the function of the hypothalamic‑­pituitary‑gonadal axis, and to determine their secondary effects in male patients. The present study was a case‑controlled study conducted in Basrah, Iraq. Of the 152 participants who met the inclusion criteria, 100 patients used different types of GCs. Of these 100 patients, 57 patients (57%) were current GC users, and 43 patients (43%) were not currently using GCs (had not used GCs in the past 30 days). The control group was comprised of 52 men (34.21%), considered as healthy participants, although 7 men (13.65%) were biochemically diagnosed with hypogonadism. Current GC exposure significantly decreased the total and free testosterone levels, whereas previous GC exposure increased estradiol (E2) levels, with the 31 patients on oral dexamethasone (cumulative dose, 18.9 mg) exhibiting a 7.5‑fold increased risk of being diagnosed with hypogonadism. For previous GC users, a significant increase in the E2 level was observed, whereas all other gonadal hormonal levels were within normal reference ranges, including the total and free testosterone levels. The total cumulative dose of equivalent GCs was 240 mg, which resulted in a decrease in total testosterone levels, and subsequent hypogonadism. Oral dexamethasone at a lower total cumulative dose resulted in hypogonadism.

1 January 2014 in Indian Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
JAJawad H Ahmed
Jawad H Ahmed
MZMaysaa B Zubairi
Maysaa B Zubairi
SASawsan S Al-Haroon
Sawsan S Al-Haroon
Objectives: To evaluate hepatoprotective potential of carvedilol, prazosin, metoprolol and prazosin plus metoprolol in paracetamol-induced hepatotoxicity. Materials and Methods : Thirty-six male rabbits were divided into six groups, six in each, group 1 received distilled water, group 2 were treated with paracetamol (1 g/kg/day, orally), group 3, 4,5 and 6 were treated at a dose in (mg/kg/day) of the following: Carvedilol (10 mg), prazosin (0.5 mg), metoprolol (10 mg), and a combination of metoprolol (10 mg) and prazosin (0.5 mg) respectively 1 h before paracetamol treatment. All treatments were given for 9 days; animals were sacrificed at day 10. Liver function tests, malondialdehyde (MDA) and glutathione (GSH) in serum and liver homogenates were estimated. Histopathological examinations of liver were performed. Results: Histopathological changes of hepatotoxicity were found in all paracetamol-treated rabbits. The histopathological findings of paracetamol toxicity disappeared in five rabbits on prazosin, very mild in one. In carvedilol group paracetamol toxicity completely disappeared in three, while mild in three rabbits. Paracetamol hepatotoxicity was not changed by metoprolol. In metoprolol plus prazosin treated rabbits, moderate histopathological changes were observed. Serum liver function tests and MDA in serum and in liver homogenate were elevated; GSH was depleted after paracetamol treatment and returned back to the control value on prior treatment with prazosin. MDA in serum and liver homogenate, alkaline phosphatase, total bilirubin were significantly decreased after carvedilol and prazosin plus metoprolol treatments. Conclusion : Carvedilol and prazosin are hepatoprotective in paracetamol hepatotoxicity, combination of prazosin and metoprolol have moderate, and metoprolol has a little hepatoprotection.

31 October 1991 in Pharmacological Research
Verified
Journal Article
Closed access
JAJ.H. Ahmed
J.H. Ahmed
PMP.A. Meredith
P.A. Meredith
HEH.L. Elliott
H.L. Elliott

1 January 2017 in Journal of Complementary Medicine Research
Verified
Journal Article
Open access
JAJawad Ahmed
Jawad Ahmed
IAIsra Abdulmajeed
Isra Abdulmajeed
The results showed that extract possesses significant antioxidant, antinociceptive and anti-inflammatory effects, and these affirm the reasons for its folkloric use.